We also used the well-known DNMT1 inhibitor 5-aza45 to address whether DNMT1 regulates cell surface HLA-G expression of tumor cells and evaluated its effect on subsequent CAR-NK challenge. This evidence concerns the gene HLA-G and neoplasm.